A clinical trial relevant to corticotropin related research has reached completed status as of October 2, 2026. The study, titled "Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving," was registered under identifier NCT05305404. It was conducted as an Early Phase 1 trial. The trial's status is listed as completed in the registry entry. No results data or outcome summaries were included in this update. The registry entry does not provide efficacy or safety conclusions at this time. This brief reports only the status change and basic trial details as recorded. Readers interested in the background of corticotropin, including its approved regulatory status, can consult the compound overview for additional context.
Trial Linked to Corticotropin Pathway Completes: Dexamethasone Alcohol Study
See the full corticotropin overview
Source: https://clinicaltrials.gov/study/NCT05305404